MC
AGN

Maplelane Capital’s Allergan plc AGN Stock Holding History

Maplelane Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-20,000
Closed -$3.27M – 197
2017
Q4 		$3.27M Buy
20,000
+19,999
+1,999,900% +$3.59M 0.07% 107
2017
Q3 		$0 Buy
+1
New +$233 ﹤0.01% 210
2014
Q1 		– Sell
-10,000
Closed -$1.68M – 212
2013
Q4 		$1.68M Hold
10,000
– – 0.07% 109
2013
Q3 		$1.44M Buy
+10,000
New +$1.33M 0.06% 133

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Maplelane Capital's AGN Position: Q1 2018 in Review

Maplelane Capital sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 20,000 shares — an estimated $3.27M sold.

Maplelane Capital first reported a position in AGN in Q3 2013 and held it in 4 quarters. The position peaked at $3.27M in Q4 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Maplelane Capital reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Maplelane Capital sold 20,000 Allergan plc shares in Q1 2018, an estimated $3.27M.
  • Maplelane Capital first reported a position in Allergan plc in Q3 2013 and held it in 4 quarters.
  • Maplelane Capital's Allergan plc position peaked at $3.27M in Q4 2017.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Maplelane Capital's 13F filing for Q1 2018, filed 15 May 2018.